Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome
Paediatrics
Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome
Paediatrics

Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome

Haematologica. 2026 Sep 3. doi: 10.3324/haematol.2026.301245. Online ahead of print.

ABSTRACT

Not available.

PMID:42687809 | DOI:10.3324/haematol.2026.301245